Jefferies lowered the firm’s price target on Teladoc (TDOC) to $8 from $10 and keeps a Hold rating on the shares. BetterHelp data trends deteriorated again in Q1, declining about 20% year-over-year, notes the analyst, who believes expectations “may need to moderate further” and cites limited visibility into the growth strategy going forward for the firm’s Hold rating.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Teladoc call volume above normal and directionally bullish
- Teladoc price target lowered to $8 from $9.50 at BofA
- Teladoc’s Uncertain Growth Amid Declining User Base and Strategic Initiatives
- Teladoc price target lowered to $9.50 from $11 at BofA
- Cautious Hold on Teladoc Amidst Declining User Growth and Uncertain Initiatives